Bloomberg Technology10 months ago
BioAge Labs Raises $170m to Develop Therapies Using AI
BioAge Labs, a clinical-stage biotechnology company developing therapies for obesity and metabolic disease thanks to their AI-powered discovery platform, raised $170 million in an oversubscribed series...
